Share on StockTwits

Guided Therapeutics (NASDAQ:GTHP) Director Ronald W. Hart sold 7,500 shares of the stock in a transaction that occurred on Wednesday, July 2nd. The stock was sold at an average price of $0.50, for a total value of $3,750.00. Following the sale, the director now directly owns 1,159,027 shares of the company’s stock, valued at approximately $579,514. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Shares of Guided Therapeutics (NASDAQ:GTHP) traded down 0.19% on Tuesday, hitting $0.483. The stock had a trading volume of 35,650 shares. Guided Therapeutics has a 1-year low of $0.47 and a 1-year high of $0.98. The stock has a 50-day moving average of $0.68 and a 200-day moving average of $0.73. The company’s market cap is $34.9 million.

Guided Therapeutics, Inc is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.